HeraMED Limited (ASX:HMD)

Market Cap	9.63M
Revenue (ttm)	364.33K
Net Income (ttm)	-5.49M
Shares Out	875.60M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,541,386
Average Volume	2,351,008
Open	0.0100
Previous Close	0.0100
Day's Range	0.0090 - 0.0110
52-Week Range	0.0090 - 0.0310
Beta	0.34
RSI	35.89
Earnings Date	May 28, 2025

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It also provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a remote fetal heart rate monitoring solution. The company has a collaboration agreement with Mayo Clinic for the development of its HeraCARE pregnancy management platform; and Broward Health for deployment of its HeraCARE to deliver care outcomes for pregnant moth...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HMD

Financial Performance

In 2024, HeraMED's revenue was 364,328, a decrease of -39.90% compared to the previous year's 606,226. Losses were -5.49 million, -18.96% less than in 2023.